Mihail Obrocea
Equibles does not estimate personal net worth.
About Mihail Obrocea
MAIA Biotechnology, Inc. reported in an 8-K filed November 15, 2023 that Mihail Obrocea was terminated as Chief Medical Officer, effective November 10, 2023. The proxy statement of MAIA Biotechnology, Inc. reports total compensation of $851,494 for Mihail Obrocea in fiscal 2022, including a base salary of $391,083. Disclosed compensation is on record for 2 fiscal years.
“On November 10, 2023, Joseph McGuire and Dr. Mihail Obrocea were terminated from their positions as Chief Financial Officer (and principal financial and accounting officer) and Chief Medical Officer, respectively, of the Company, effective immediately, as part of the Company's effort to streamline operations.”
Affiliation history
-
MAIA Biotechnology, Inc. (MAIA)
Proxy statement
Start not stated–2023-11-10
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | MAIA Biotechnology, Inc. (MAIA) | Chief Medical Officer | $391,083 | $851,494 |
| 2021 | MAIA Biotechnology, Inc. (MAIA) | Chief Medical Officer | $162,500 | $2,145,986 |